Literature DB >> 3186983

Pulmonary alveolar proteinosis: CT findings.

J D Godwin1, N L Müller, J E Takasugi.   

Abstract

In pulmonary alveolar proteinosis (PAP), a proteinaceous material accumulates in the alveolar air spaces, causing hypoxemia, restrictive lung disease, and dramatic abnormalities on chest radiographs. Complications are unusual, but of the ones that do occur, infection, particularly with Nocardia asteroides, and fibrosis are the most common. Few computed tomographic (CT) studies of this condition have been reported. The CT scans of nine patients with PAP were reviewed. Varying combinations of air-space and interstitial patterns were seen. The CT appearance of air-space disease ranged from ill-defined nodules to patchy consolidation to large regions of confluence. Air-space consolidation was sometimes sharply demarcated from surrounding normal lung tissue, which created a geographic pattern. Despite the predominance of air-space patterns, air bronchograms were not a prominent feature. CT showed the interstitial component of disease and the extent of disease more clearly than did plain radiography. In two cases, CT demonstrated focal pneumonia that was not visible on the radiographs.

Entities:  

Mesh:

Year:  1988        PMID: 3186983     DOI: 10.1148/radiology.169.3.3186983

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  13 in total

Review 1.  Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis.

Authors:  P L Shah; D Hansell; P R Lawson; K B Reid; C Morgan
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

2.  Healthy 11-year-old girl with a 3 month history of dyspnea, non-productive cough and mild chest pain.

Authors: 
Journal:  J Natl Med Assoc       Date:  2000-02       Impact factor: 1.798

Review 3.  Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.

Authors:  Kendra J Greenlee; Zena Werb; Farrah Kheradmand
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

4.  Progressive dyspnea associated with a crazy-paving appearance on a chest computed tomography scan.

Authors:  Nimrod Maimon; Narinder Paul; Gregory P Downey
Journal:  Can Respir J       Date:  2006 Jul-Aug       Impact factor: 2.409

5.  Acute respiratory failure caused by secondary alveolar proteinosis in a patient with acute myeloid leukemia: a case report.

Authors:  A Gacouin; Y Le Tulzo; E Suprin; E Briens; M Bernard; C Camus; R Thomas
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

6.  High-resolution computed tomography to differentiate chronic diffuse interstitial lung diseases with predominant ground-glass pattern using logical analysis of data.

Authors:  Sophie Grivaud Martin; Louis-Philippe Kronek; Dominique Valeyre; Nadia Brauner; Pierre-Yves Brillet; Hilario Nunes; Michel W Brauner; Frédérique Réty
Journal:  Eur Radiol       Date:  2009-12-08       Impact factor: 5.315

7.  Primary pulmonary alveolar proteinosis: computed tomography features at diagnosis.

Authors:  Laureline Berteloot; Rola Abou Taam; Sophie Emond-Gonsard; Tania Mamou-Mani; Karen Lambot; David Grévent; Caroline Elie; Muriel Le Bourgeois; Christophe Delacourt; Francis Brunelle; Jacques de Blic
Journal:  Pediatr Radiol       Date:  2014-03-06

Review 8.  Rare lung disease II: pulmonary alveolar proteinosis.

Authors:  Stephen C Juvet; David Hwang; Thomas K Waddell; Gregory P Downey
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409

9.  Secondary pulmonary alveolar proteinosis: a confusing and potentially serious complication of hematologic malignancy.

Authors:  Jonathan H Chung; Sudhakar J Pipavath; David H Myerson; David Godwin
Journal:  J Thorac Imaging       Date:  2009-05       Impact factor: 3.000

10.  CT findings in pulmonary alveolar proteinosis: serial changes and prognostic implications.

Authors:  Bo Da Nam; Tae Jung Kim; Man Pyo Chung; Myung Jin Chung; Tae Sung Kim; Kyung Soo Lee
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.